SchizophreniaCare360 Videos

Videos

A Step Toward Improving Cognition in Patients With Serious Mental Illness

01/15/2021

Kristin Bigos, PhD, of Johns Hopkins Medicine, Baltimore, Maryland, discusses research that could advance the development of treatments focused on cognition in people with schizophrenia or other serious mental illness.

Kristin Bigos, PhD, of Johns...

01/15/2021

Psych Congress Network

Videos

Maximizing the Benefits of Antipsychotic Medications

12/07/2020

Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses strategies for treating patients who are still psychotic while taking the maximum dosage of a long-acting injectable medication.

Psych Congress Steering...

12/07/2020

Psych Congress Network

Videos

Dr. Rakesh Jain on Using LAIs in Patients With Dementia and Delusions

11/02/2020

Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the use of long-acting injectables for patients with dementia and paranoia or other delusions.

Psych Congress Steering...

11/02/2020

Psych Congress Network

Videos

What Does Imaging Data Show Us About Schizophrenia?

10/22/2020

In this video from Psych Congress 2020, Sanjai Rao, MD, discusses whether imaging data could play a role in diagnosing schizophrenia.

In this video from Psych...

10/22/2020

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

SchizophreniaCare360 Videos

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products